Jamie Kitt

I am a dual-accredited Cardiology & General Internal Medicine (GIM) Consultant trained throughout Thames Valley in England and a Post-doctoral Research Fellow in RDM CV Medicine. I have sub-specialty training in advanced echo, Cardiac magnetic resonance (CMR), Cardiac CT, and Hypertensive disorders of pregnancy.

After developing an interest in scientific research during the final year research project of a Biological Natural Sciences degree in Cambridge University, I transferred onto a graduate medical degree course at the University of Oxford. I worked on research projects where possible during my initial medical training, including leading recruitment of the INSIGHT H5N1 study from 2011-2013 under Prof Brian Angus in the Nuffield Department of Medicine. I then began training as a cardiology speciality registrar and developed sub-specialist interests in Obstetric cardiology, Hypertension and Cardiac imaging, which is where a research interest began in hypertensive pregnancy within Paul Leeson’s group of RDM CV Medicine.

Under the supervision of Prof Paul Leeson, Prof Richard McManus and Prof Adam Lewandowski, I was awarded a British Heart Foundation clinical research training fellowship to investigate the mechanism and potential treatment of the long-term cardiovascular complications that occur following Hypertensive pregnancy. The funding was used to run a randomized controlled trial on the post-partum self-management of hypertensive pregnancy (POP-HT). 

Following completion of his DPhil he has analysed and drafted the key publications from the Physician Optimized Post-partum Hypertension Treatment (POP-HT) trial, which were presented at the American Heart Association’s Late Breaking Scientific Sessions in Philadelphia in November 2023. The primary outcome paper was published in JAMA to coincide with AHA and the key secondary imaging outcome paper was published in CIRCULATION in February this year with an accompanying Circulation on the run podcast covering this vital area of research (Circulation on the Run: Circulation February 13, 2024 Issue (libsyn.com). The trial identified a new paradigm as to how we understand, and how we can prevent, links between hypertensive pregnancy and long-term cardiovascular risk. This work has the potential to transform care for women affected by hypertensive pregnancy in the postpartum period. The vascular sub-study work has been presented at the British and Irish Hypertension Society, for which he was awarded the early career research award, and has been invited to present this body of work at the Australian Hypertension Society in December 2025.